医疗设备制造商丹纳赫（DHR）今日盘中大涨7.18%，引发市场广泛关注。这一显著涨幅主要源于公司发布的强劲第一季度财报。
根据公司公布的数据，丹纳赫第一季度调整后每股收益达1.88美元，大幅超过分析师预期的1.64美元。公司营收也超出预期，达到57.4亿美元，高于分析师预计的55.9亿美元。这一亮眼业绩主要得益于公司呼吸检测试剂盒需求强劲。丹纳赫预计2025年全年调整后每股收益将在7.60美元至7.75美元之间，整体符合市场预期。
尽管面临潜在的关税压力，丹纳赫对未来前景保持乐观。公司预计2025年将产生"数亿美元"的增量关税成本，但表示将通过调整生产布局、优化供应链、征收附加费和采取额外的成本节约措施来应对这一挑战。此外，公司预计2025年剩余时间的终端市场需求将与第一季度保持相对一致，进一步增强了投资者信心。在当前复杂的经济环境下，丹纳赫的强劲表现和积极展望无疑为投资者带来了信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.